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vAbstract
Venous thromboembolism (VTE) is a vascular disease in which a blood clot forms inside of a vein, most often
deep in the legs, groin, or arm. Two types of VTE exist, deep vein thrombosis (DVT) and pulmonary embolism (PE).
DVT occurs when a clot in a deep vein forms, risking embolism and causing swelling as the clot obstructs blood
flow. An embolism occurs when a part or all the thrombus breaks off and travels in the circulation, getting lodged
in the lungs. A pulmonary embolism is a very serious medical condition and can be fatal if not treated immediately.
Current guidelines for treatment recommend oral administration of blood thinners, but in cases where alternative
measures are needed, intervention with catheter directed thrombolysis (CDT) is commonly attempted. Methods for
catheter directed thrombolysis vary greatly, but a regular feature is the option for mechanical agitation. The most
commonly seen mechanic for mechanical agitation involves an expanding mesh geometry that is expanded either
behind or within the thrombus. The issue with mesh geometries lies in the delicate cell lining of the vessel. Any
injury to the vessel lining can cause the recurrence of a VTE as a post treatment complication. Mesh geometries
risk breakage, and the expanding radial size can risk contact with the vessel lining. To overcome this disadvantage,
we present a novel design for mechanical agitation in catheter directed thrombolysis. In this novel method, a rail
mounted fin geometry that is constrained to the centerline is advanced and retracted through a sample thrombus
to break up the thrombus and restore flow through the vessel. To this end to study this geometry performance,
three performance objectives were outlined. The objectives were peak penetration force, average forward movement
force, and average mass of sample removed. 3D printed geometries varying in two angles were tested on porcine
thrombus samples for the three objectives. Results suggest that the angle of pitch relative to the front face of the
geometry, is very impactful on penetration and forward movement.
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I. INTRODUCTION
DEEP venous thrombosis and pulmonary embolisms affect as many as 900,000 people in the UnitedStates each year, with 60,000-100,000 fatalities being attributed to venous thromboembolism. [1]
Among those affected, about one-half will have long term complications known as post-thrombotic
syndrome. Numerous factors can increase the risk of VTE in a patient. Injury to a vein can trigger
the development of a VTE. Long periods of immobilization can severely increase the risk of a DVT,
such as an extended hospital stay or being bedridden. The deep veins in the legs depend on muscle
movement to move blood back up the body. Extended time lying down can cause blood to pool in the
lower extremities, increasing the likelihood of a clot forming. DVT has been shown to strongly correlate to
invasive surgery, any form of decreased blood flow, an increase in estrogen, heart or lung disease, age, or
previous history of DVTs. Additionally, nearly 50 percent of all blood clots occur during or immediately
following a hospitalization or surgery. As medical technology advances and care becomes more readily
available to all, VTE will only become more and more prevalent as a post care concern.
Conservative estimates for the annual cost of treating newly diagnosed VTEs are between $ 7-10
billion, for 375,000 to 425,000 newly diagnosed, medically treated incident cases. [2] Estimates for the
total economic impact of VTE, including the value of lost economic output due to premature mortality,
go up to $69 billion dollars annually. Venous thromboembolism is a widespread problem that will only
become more relevant, creating the need for improvements in techniques and devices to treat the disease.
A. Device Introduction
The guideline for treatment of VTE calls for mainly the use of oral pharmaceutical blood thinners. [3] In
the cases where the patient’s co-morbidities increase the risk when using blood thinners, or they are unable
to take the blood thinners due to other concerns, intervention is necessary. [4] Interventional treatment
options vary greatly depending on the patients specific needs, from local thrombolyic delivery through
catheter directed thrombolysis (CDT) to mechanical agitation. [5] Often, a practitioner will incorporate
more than one treatment modality in order to maximise the chances of success. Mechanical agitation
as an adjunct to catheter directed thrombolysis can take many forms, from a slightly maneuverable tip,
to a curved wire that spins with a high rotation per minute (RPM), to an expanding mesh basket that
Dr. Guy Genin is the Co-Director of the NSF Science and Technology Center for Engineering MechanoBiology and the Harold and
Kathleen Faught Professor of Mechanical Engineering in the Departments of Mechanical Engineering and Materials Science Department of
Neurological Surgery at Washington University in St. Louis
Dr. Mohamed Zayed is the Director of the Vascular Surgery Biomedical Research Laboratory at Washington University School of Medicine
2encapsulates the target. A figure displaying current options for mechanical agitation are shown below in
figure 1. As the figure shows, currently available devices for mechanical lysis lack protective measures
to ensure that the device has minimal to no contact with the delicate vessel lining. The slightest injury to
the vessel lining during mechanical agitation can trigger further VTE formation, rendering any treatment
that risks such a thing ineffective.
Fig. 1 – Table of mechanical lysis devices.
This thesis is focused on further optimization of a novel method for mechanical agitation; rail mounted,
single degree of motion mechanical agitation. In this method, an agitator is pushed over a midline
constrained guide rail back and forth through a thrombus to loosen any emboli and to reestablish flow.
The key advantage this technique has over competing designs is the ensured safety to the vessel walls.
As stated previously, an injury to a vessel wall can trigger the formation or propagation of VTEs. A
treatment that removes a large segment of thrombus and restores flow will be pointless if it risks damage
to the endothelial cell lining of the vessel wall and triggers future VTE formation. In a rail mounted
system, the agitator will always travel along the designated midline path, and if the radius of the agitator
3is sufficiently smaller than the radius of the vessel, there is a minimal risk of any contact or damage to
the vessel walls.
B. Optimization Objectives
This thesis will focus on the design of the rail mounted agitator fin geometry and testing of different
variations, due to a lack of studies on this specific scenario. The objective of this work is to find the
agitator geometry design that will travel through a sample clot with the least amount of force necessary,
in addition to removing as much of the sample as possible in a single pass. These optimization objectives
can be summarized in the following three points.
1) Penetration of the thrombus surface by the front face of the agitator with minimal force
2) Slicing and cutting by fins during forward movement with minimal force
3) Maximal removal of chips/emboli by backward movement with minimal force
C. Operating Assumptions
We operated with several assumptions, to constrain the optimization variables and simplify the problem.
In the design of the agitator, only two variables were altered, and all other parameters were unchanged.
This list of unchanged parameters includes:
• the central rail size
• the radius of the fins
• the curvature of the fins
• the number of fins
• the spacing of the fins
• the material used in the 3D printing
• the percentage fill of the 3D printing
We will also assume that the negative pressure suction which follows the mechanical agitation step will
be powerful enough to remove any and all emboli created during the procedure. The purpose of these
assumptions is to limit and to focus the scope of this thesis.
D. Experimental Design Variables
The geometries tested in this experiment are all variations of the same finned design, with two angles
being changed, α and θ. α refers to the angle between the fin and the surface of the rod, as labeled below
in figure 2. α angle is shown as right angle between fin and rod surface. α is calculated as the tilt from
perpendicular plane. When the angle is 90, α=0.
4Fig. 2 – Left: Front face of the (0,0) geometry. Right: Front face of the (45,70) geometry.
θ refers to the angle between the front face of the fin and the axis of the rod, as labeled below in figure
3. θ angle is shown as the pitch of the front face, with respect to the front face plane. For a 90-degree
angle in the (0,0) geometry, θ=0.
Fig. 3 – Right: Side view of the (0,0) geometry. Left: Side view of the (0,70) geometry.
There were 3 α angle variations used, 20 degrees, 45 degrees, and 70 degrees. There were 4 θ angle
variations used, 0 degrees, 15 degrees, 30 degrees, and 45 degrees. Each α variation was applied to each
θ variation for a total of 12 geometry variations. Finally, a control geometry of (0,0) was also tested for
a total of 13 geometry variations. A chart showing all geometry variations of α and θ is shown below,
under figure 4. The chart does not include the control geometry of (0,0).
5Fig. 4 – A chart summarizing the different agitator geometries that were tested. This chart does not include the control
geometry of (0,0).
E. Anticipated Results
For each of our three optimization objectives, a variable is being altered which we believe will affect
each objective.
The first objective was penetration of the thrombus surface by the front face of the geometry. To
maximize the pressure applied at a constant force, we thought to minimize the area of front face. This
is related to the θ angle, as a steeper slope will create a smaller area in the front face to penetrate the
sample. Thus, we hypothesize that geometries with a higher θ value will perform better at this objective.
We also hypothesize that α values should have minimal to no impact on penetration of the sample surface
as we do not believe it will impact the penetrative force.
The second objective was optimal slicing by the fins of the agitator during forward movement. To
minimize the force needed to slice the thrombus as the agitator is pushed forward, we thought to utilize
shear angle cutting. Shear angle cutting differs from non-shear angle cutting in that it adds a dimension,
going from two-dimensional cutting to three-dimensional cutting. [6] With this method, the same force
can be used to exert a higher pressure on the sample to be cut, as the contact area is reduced. A figure
illustrating the difference is shown below, under figure 5. We hypothesize that a steeper slope, or a higher
θ value, will perform better at forward movement, and that α values will have minimal to no impact on
forward movement.
Fig. 5 – Non-Shear Angle Cutting versus Shear Angle Cutting
The final objective was the effective removal of samples with minimal force by backwards movement.
To maximize the drag on the chips created during forward movement, curved fins would have been ideal.
However, preliminary geometry printing found great difficulty in accurately and reliably printing curved
fins. Therefore, the α angle was varied instead of fin curvature. While having a weaker effect than curved
fins, we hypothesize that a higher α angle will make the geometry remove more of the sample during
backwards movement. We also hypothesize that θ values will have minimal to no impact on this objective.
In Summary: For the first objective of efficient penetration of the sample surface by the geometry front
face, we believe that higher θ values will perform better and that α values will have little to no effect.
6For the second objective of optimal slicing by fins during forward movement, we believe that a higher θ
value will perform better and that α values will have little to no effect. For the third objective of effective
removal of samples with minimal force, we believe that a higher α will perform better and that θ will
have little to no effect.
II. METHODS
A. Experimental Methodology
In this experiment, varying agitator geometry designs were run for a single loop through 20 mL blood
clot samples created in Falcon 50 mL conical centrifuge tubes. The agitator geometries were attached to
a rail guided linear actuator to ensure consistent movement. The movement was constrained to a vertical
single degree of motion, with the blood clot samples being placed underneath the set up. In the connection
between the actuator and the agitator geometry, a SMD S300 load cell was placed such that the agitator
geometry was hanging from it and any forces, including the weight, acting upon the geometry would
be picked up by the load cell. The force readings were then analyzed for the different segments of the
motion. Averages were taken for the peak penetration force, the forward motion through the sample, and
the backward motion returning to position. The average forces were then normalized with respect to the
weight of the geometry. Additionally, the sample was weighed before and after the experiment to get a
measure of the mass of the sample that was removed. After analysis of the blood clot samples, additional
experiments were run on a non-fibrous agarose material, to provide contrast to the fibrous clot samples.
The agar sample experiments were run only on the geometries with an α of 0.
B. Sample Preparation and Rheometer Measurement
The mechanical properties of blood clots vary immensely. Variables such as age of the patient, age
of the thrombus, location of the thrombus, reason for thrombus formation, and medical history can all
drastically change the properties of a thrombus. There are three general classifications for DVT, based on
how long the clot has been present. When a clot is 14 days old or younger, it is known as an acute DVT.
These types of clots are the softest and the least attached to the vessel walls. This is the type of clot that
is the target for this study. Acute clots often pose the highest risk, as the weak attachment to the vessel
walls pose a higher threat of breakage, and ultimately, symptomatic pulmonary embolism (PE).
The intermediary stage is known as a subacute DVT, and it contains clots that are between 14-28 days
old. At this point, the clot has gotten slightly harder, and the clot has started to form connections to the
vessel wall. It is on its way to the final step. In the last classification, chronic DVTs are clots that have
been present for over 28 days. Chronic DVTs have hardened and formed connections with the vessel
walls, becoming scarred tissue that is very difficult to undo. Chronic DVTs are often associated with a
lower risk, as the connections that anchor the hardened thrombus to the vessel will prevent the thrombus
from breakage.
The target for this study was acute DVT. For any experimental results to be reliably reproduced, the
wide range of possible mechanical properties of blood clots had to be narrowed down and quantified. The
values we were interested in were the oscillatory shear modulus, the density, and the age of the clot.
The blood used was food grade porcine blood, obtained from Olive Supermarket. Our lab had been
purchasing clotted porcine blood from Olive Supermarket for over a year and have used it as a surrogate
to mimic the viscoelastic mechanical properties of an acute stage DVT. In this experiment, we wanted
to coagulate the blood inside the centrifuge tubes, rather than slicing out an appropriate sample from
a tub as we had been doing. The reasoning was that it would better mimic wall adhesion forces if the
clot was able to form inside the tube, as opposed to being placed inside. If the sample were cut out and
placed inside, there would be issues with replicability as the geometry of the sample would be difficult to
replicate every time and would be inconsistent at best. The adhesion of the sample to the tube would vary
drastically and be difficult to measure. By coagulating the blood inside the tube, the sample geometry
could be guaranteed to be the same, as the liquid would fill the shape of the container before solidifying.
7The supplier sold the blood as dehydrated blood, and the recipe to create the coagulated blood was 60%
cold water and 40% dehydrated blood, by volume. No other additives were used. For the 20 mL volume
of sample, we used 12 mL of cold water and 8 mL of dehydrated blood. The samples were used in
between the 24-48 hour period after the sample was created.
The agar gel sample preparation used 1.5% agar gel by weight. To prepare the agar gel samples, 7.5
g of agar powder was added to 500 mL of boiling water and stirred using a magnetic stirrer until the
solution was homogenous. Before the solution was allowed to cool and solidify, a pipet was used to put
20 mL of the solution into the same 50 mL Falcon centrifuge tubes. The samples were then cooled in
room temperature and used within 24 hours.
To measure the oscillatory shear modulus, we used a TA AR-G2 rheometer. A 13/16-inch arch punch
was used on a sample of blood clot prepared in a petri dish to create disks of sample to be measured.
The same size arch punch was used on 150 grain sand paper, and the resulting sandpaper disks were
attached to the side of the rheometer head in contact with the sample and the petri dish that the sample
was placed on. This aided with surface interaction and worked to prevent slipping. The samples were
placed in a 40mm Falcon petri dish on top of the sand paper disks. The petri dish was then inserted into
the rheometer.
The rheometer had three programmed steps. The first, a squeeze/pull off test, slowly lowered the
rheometer head until the sample exerted a steady normal force of 0.02N (+/- 0.01). This served to set the
initial height of the head on top of the sample for the other testing steps. The graph of the normal force
with respect to time is given below in figure 6. The characteristic dip in force, caused by surface tension,
is then followed by a steady increase until the desired normal force of 0.02N.
8Fig. 6 – Squeeze/pull off test step graph of normal force (N) to time (s).
The next programmed rheometer test step is the frequency sweep step. Initially, the test was performed
at a range of angular frequency from 0.1-10 rad/s, with 10 steps taken logarithmically. This yielded some
useful data points, but the second half of the test yielded more and more unstable results. The average
elastic modulus taken from the usable data point range was 29.97 (+/- 3.82) Pascals. An example of
an unstable data point is shown below on the left in figure 7. This data point is unreliable because the
expected and actual displacement lines are very different. A usable data point would have the expected
and actual displacement lines follow a similar path, as is shown below on the right in figure 7.
9Fig. 7 – Left: Graph of expected angular displacement (blue) to actual angular displacement (red). Sample taken at
2.512 rad/s angular frequency. Right: Graph of expected angular displacement (blue) to actual angular displacement (red).
Sample is taken at 0.3891 rad/s angular frequency, from frequency sweep step of 0.1-1 rad/s.
It was determined that the range of angular frequency was too high, and at high angular frequencies
the rheometer head was damaging the structural integrity of the sample, rendering any readings past that
point unusable. A fresh sample was inserted, with the range of angular frequency changed from 0.1-10
rad/s to 0.1-1 rad/s, with the same number of steps. The adjusted frequency sweep step test that followed
yielded reliable data points at every angular frequency increment, for an average elastic modulus of 29.93
(+/- 0.54) Pascals, which was consistent with the first readings. The full set of rheometer data can be
found in appendix A.
Finally, the step after the frequency sweep step was the strain sweep step. Where the frequency step
varied by angular frequency, strain sweeps held the angular frequency constant and varied the strain. In
this case, the strain was varied from 0 to 0.1, at a constant angular frequency of 0.5 rad/s. The angular
frequency was decided upon due to reliable readings at around 0.5 in the frequency sweep step. The
resulting data gave an average elastic modulus of 26.85 (+/- 1.70738) Pascals. A graph of the expected to
actual displacement for a strain of 0.03985 is shown below, in figure 8. The actual displacement closely
follows the expected displacement, showcasing a reliable data point.
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Fig. 8 – Graph of expected angular displacement (blue) to actual angular displacement (red) during strain sweep step.
Taken at an angular frequency of 0.5 rad/s.
The density was taken by weighing the sample in the Falcon 50 mL centrifuge tubes and assuming a
volume of 20 mL. The average density of all samples was found to be 1.0033 g/mL, which was is similar
to known values for porcine clots (1.06+/- 0.01 g/mL). [7] The values should be similar to the density of
water, as the majority of the weight is comprised of water.
C. Experimental Apparatus Set Up
The apparatus consisted of two independently controlled sets of instruments that were attached to each
other and controlled from the central computer.
The linear actuator set consisted of a 400mm linear stage actuator with a rail guide, powered by a
Nema23 24-volt, 3-amp stepper motor. The rail guide was an SFU 1605 level C7 ballscrew. To control
the linear actuator, an Arduino was connected to a KNACRO TB6560 stepper motor driver board, which
was in turn connected to the Nema23 stepper motor. From the moment the Arduino code was uploaded
from the PC, the motor would wait two seconds, move 11.3 cm down, wait one second, and move 11.3
cm up. Then it would rest until the next trial. The Arduino code used is attached in appendix B.
The second set, the force transducer set, utilized a SMD S300 load cell, rated for 2 kg-force. The load
cell was connected to an attachment which sent signals to a National Instruments Data Acquisition device
(NI DAQ), which was in turn connected to the PC. National Instruments LabView was used to create
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and control the virtual instrument (VI). The VI was run simultaneously with the Arduino commands, and
recorded force as a function of time.
A connective piece (Part A), was designed and 3D printed to connect the linear actuator stage and the
load cell. They were connected to the linear actuator stage by four 6mm hex bolts. The load cell was
fastened into place by two 20mm long, 6mm bolts. Part A also connected the sensor attachment, which
sent signals to the NI DAQ from the load cell. That was connected on the side by a 4mm hex bolt and
nut. Part A is shown below in Figure 9.
Fig. 9 – Part A with labels for bolt and instrument placement.
Another connective piece, part B, was designed and 3D printed to connect to the load cell and allow
for easy geometry replacement. The piece was connected to the load cell by a one inch long, 6-32 screw.
The different geometries were connected to part B using a safety pin, for easy exchange. Part B is shown
below in Figure 10.
Fig. 10 – Part B with labels for bolt and pins.
D. Full Schematic
The full schematic is shown below with labels for the respective parts, under figure 11.
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Fig. 11 – Full schematic of experimental setup.
E. Experiment Methodology
The experiment trials began by weighing the sample of thrombus inside the centrifuge tube, without
the screw on cap. After recording the before weight, the sample was inserted into the set up and centered
axially. The Arduino code was then initialized from the PC. As soon as the Arduino upload was complete,
the VI data collection was started. The linear actuator pushed the geometry through the sample and back,
while the load cell collected the force data. Once the data collection was finished, the VI was turned off.
Then, the geometry was removed, washed with water, dried, and reinserted. Each geometry was tested
three times, replacing the clot samples in each trial. If data collection with the geometry was finished,
the next geometry was inserted instead. Then the thrombus sample was weighed and the after weight was
recorded. The collected data was saved as an image, and the trial data was exported into Microsoft Excel
for analysis. The increments of interest with respect to time were recorded for averaging. A pre-motion
increment, a peak penetration increment, a forward motion increment, and backwards motion increment
were all recorded for each trial, to average. At every instance of the motor starting or stopping, a large
spike is seen as the motor initialized. This spike was used as reference in the analysis. An example graph
and the increments are shown below in Figure 12.
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Fig. 12 – Sample force to time graph from trial 2 in blood clot for (15,70) geometry.
From right to left:
• Blue increment shows an example of average weight force. This is before the linear actuator begins
movement, and the only force acting on the load cell is the weight of the geometry. This is used to
normalize the rest of the readings.
• Grey increment shows an example of peak penetration force. Usually a peak is seen as the geometry
tip makes contact with the sample surface, and before it penetrates through the sample surface.
• Red increment shows an example of average forward force. After the peak penetration, there is
usually a valley as the penetration finishes, and the sample begins its movement through the sample.
The forward force is taken from the valley after the peak penetration until the geometry finishes its
movement, which can be seen in the spike in the data.
• Green increment shows an example of average backwards force. After the one second increment
after forward movement, the motor begins to move the actuator stage backwards, as evidenced by
the plateau followed by a spike. The backwards force is taken from the spike until about 0.5 seconds
after, when the geometry leaves the sample.
III. RESULTS AND DISCUSSION
A. Smoothed Force Graphs
The data was smoothed out and zeroed using a Matlab code. The Matlab analysis also converted the
time measurements to distance measurements. The result was a distance to force graph of the three trials
per geometry design. This visualization of the data allowed for an easier analysis of the trends between
the penetration tendencies. The data conversion was done for both the blood clot samples as well as the
agar samples. The Matlab code used for the smoothing can be found in appendix C. The raw data grahs
can be found in appendix E.
The resulting thrombus sample graphs below highlights the unusual result seen in the θ variance.
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Fig. 13 – Force to displacement graphs of all geometries (α,θ) with a θ value of 20. Three trials per graph.
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Fig. 14 – Force to displacement graphs of all geometries (α,θ) with a θ value of 45. Three trials per graph.
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Fig. 15 – Force to displacement graphs of all geometries (α,θ) with a θ value of 70. Three trials per graph.
As the θ increases, one would expect the sharper geometry to require less force to exert the same
pressure, as the surface area is decreased. However, the graphs show an increasing trend as the θ is
increased, culminating in a spike in the required penetrative force at a θ of 70. This seemingly reversed
result can be explained by the fibrin network inside the clot changing the overall stiffness of the sample
when the sharp geometry indents and deforms the surface of the sample. Therefore, we would expect the
same set of experiments conducted on non-fibrous samples, like the agar samples, to have the opposite
trend, where the sharper, high θ values require the least force. The results of the agar trials can be seen
below, in figure 16.
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Fig. 16 – Force to displacement graphs of agar trials. α was held at 0, and θ was varied from 0 to 70. Three trials per
graph.
As the θ is increased, we see an overall decreasing trend in the penetrative force and forward required
force. This is as expected, with the exception to the trend occurring at θ of 20. Here, there is a surprising
peak in the penetrative force, an increase from the lower θ value of 0. This results reaffirm the unique
mechanical nature of the thrombus samples, and illustrates why designs must account for the fibrous
network inside the thrombus and cannot simply assume it to be a non-fibrous material.
There are several geometries with more variance in their trials than other geometries. The most likely
explanation for this is inconsistency in the experiment, particularly in the internal structure of the thrombus
samples. Notable examples of geometries with large variance in their trials include the (45,20) geometry
in figure 14, the (30,45) geometry in figure 15, and the (30,70) geometry in figure 16. The most likely
explanation is that there were regions with different distributions of fibrin within the thrombus sample in
those trials. In other trials the variance is smaller and not enough to overcome the trends produced by
the geometry. However, in trial 2 of the (45,20) geometry in figure 14, there was some irregularity in the
fibrin distribution in the thrombus sample that affected the force graph as the geometry pushed through
the irregular region of the sample.
In addition to the smoothing graphs, we also extracted the average peak force values per geometry
and averaged them. Because of the statistical findings that α was largely unimpactful to the objective
performance, we omitted the geometries with α values of 15, 30, and 45, leaving only geometries with
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α vales of 0. The resulting peak force graphs with standard error bars of both clot and agar samples can
be found below, in figure 17.
Fig. 17 – Forward movement peak forces per geometry with α value of 0. Varied by θ. Clot samples on left, agar samples
on right.
As the trends show in the bar graphs, the trend for the clot samples is the opposite of that seen in the
agar samples. The agar samples reflect penetration patterns for a non-fibrous solid, wherein the geometries
with a higher θ value and a sharper point, require less force to penetrate. The same surface yield pressure
can be achieved with less force because of a smaller area in the sharper geometries. The pattern observed
in the clot samples is opposite of this, which reflects the behavior of fibrous solids, wherein the increased
surface indentation without yield from the sharper geometries causes the stiffness to increase exponentially,
increasing the surface yield pressure. The θ of 20 in agar also departs from the expected pattern. This
may be due to a nonlinearity in the sample wherein the higher strain concentrations further increase the
stiffness of the agar material. In this case the sharpness of the geometry may have found a middle ground
of sorts where the geometry sharply increased the stiffness through the indentation, without providing
enough stress to penetrate the material, causing the stiffness to rise higher before penetration occurs.
The average forces and standard error bars during forward movement after penetration, or plateau forces,
are shown below in figure 18.
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Fig. 18 – Average forward forces after peak penetration per geometry with α value of 0. Varied by θ values. Clot samples
on left, agar samples on right.
In both agar and clot samples, the force applied in forward movement was noted to decrease as the θ
increased. In both cases, a sharper geometry and a higher θ value perform better at the second objective of
cutting during forward movement, after the initial penetration. However, the performance of the geometries
on the first objective of initial penetration is a major factor in forces that the vessel wall will feel, as
the forces are simply greater for the penetration, which can be seen when comparing the maximum force
values for the peak forces versus the plateau forces.
In the next graph, the ratio of peak forces during unloading to the average force during forward
movement after penetration for each geometry with an α of 0 is compared. The average of each geometry
along with error bars representing the standard error are shown below in figure 19.
Fig. 19 – Ratio of forces per geometry with α value of 0. Varied by θ values. Clot samples on left, agar samples on right.
The trend in the figure above shows a slight increase in the force applied on the clot samples as the
angle of indentation, θ, increases. This further reinforces the finding that forces are reduced by having a
lower θ, as the ANOVA analysis showed statistical significance in the variation of θ. In comparison, the
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trend in the agar samples is largely horizontal, showing the difference in mechanical behavior between the
fibrous thrombin solid samples and the non-fibrous agarose solid samples. The required surface penetration
pressure changes as the material is indented without penetration in the clot samples, and does not change
in the agar samples. The low variance with respect to the θ angle also suggests that the damaged regions
around the insertion had little contribution to the unloading.
The stiffness for the same geometries was also compiled into a bar graph. The stiffness was determined
by dividing the change in force by the change in distance during the linear portions of the force by
distance graph. The stiffness was calculated for both forward movement, during indentation, and for
backward movement, during unloading. The resulting stiffness graphs of both clot and agar samples can
be found below, in figure 20 and figure 21. The average per geometry as well as standard error bars are
plotted in each graph.
Fig. 20 – Indentation stiffness per geometry with α value of 0. Varied by θ values. Clot samples on left, agar samples
on right.
Fig. 21 – Unloading stiffness per geometry with α value of 0. Varied by θ values. Clot samples on left, agar samples on
right.
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The unloading stiffness for the thrombus samples was found to be higher for a θ of 0, which can be
explained by the indentation. In the higher θ values, the fibrous network is indented further before yielding,
which would cause further damage to the fibrous network inside the solid. For the θ value of 0, there
would have been minimal indentation and therefore minimal damage to the fibrous network, causing the
relatively higher unloading stiffness values. In comparison, the unloading stiffness of the other geometries
are lower, because of the damage done by the indentation without yield. The unloading stiffness trend
for the agar samples are the opposite of the trend for thrombus samples. This supports the indentation
damage analysis, as there was no fibrous network to be damaged in the agar samples, and no factor to
affect the unloading stiffness values as there was in the thrombus samples.
B. ANOVA Analysis
A two-factor analysis of variance (ANOVA) with replication test was run on all four analyzed incre-
ments; the average forward force, the average backwards force, the average peak penetration force, and the
average change in weight. In all cases, the null hypothesis was the same. H1 is that the θ groups have no
significant difference in performance. H2 is that the α groups have no significant difference in performance.
H3 is that the combination of the θ and α groups have no significant difference in performance. This way,
by rejecting or failing to reject θ and/or α, we can confirm or deny our initial hypothesis for each of our
design objectives. The two factors were the two varied angles, α and θ. The ANOVA was first run for all
four with a significance level of 0.05, or 5%. Then the ANOVA was run again with a lower significance
level of 0.01, or 1%. Each of the three design objectives are analyzed in detail along with the relevant
force set ANOVAs in the following sections. A complete chart of all the data and all ANOVA analysis
can be found in appendix D.
The first objective of efficient penetration of the sample surface involves the ANOVA for peak pene-
tration force. At a significance level of 0.05, the critical F value for θ was 3.403 and the critical F value
for α was 3.009. The F value for α was 0.535, meaning we fail to reject our null hypothesis that α has
no significant change in performance. This is consistent with our hypothesis, where we assumed that α
would have little to no effect. The F value for θ was 46.646, meaning we were able to soundly reject
the first null hypothesis that θ had no significant impact on performance. This is along the same lines as
our hypothesis, but the trend is reversed. We hypothesized that a steeper front face, or a higher θ, would
perform better at penetration and need less force. However, the data shows the opposite trend, with a θ
of 20 performing far better than a θ of 45 or 70. Finally, the critical F value for the interaction between θ
and α was 2.508, and the actual F value was 1.338, meaning we are unable to reject that the combination
of θ and α had no significant difference in performance.
The ANOVA test was repeated at a significance level of 0.01. The critical F value for θ changed to
5.614 and the critical F value for α changed to 4.718. The critical F value for the interaction between θ
and α changed to 3.667. At this higher significance level, our results were unchanged; the null hypothesis
that θ has no significant impact on performance was still soundly rejected and we failed to reject the
other two null hypotheses that α has no significant impact and that the combination of α and θ has no
significant impact.
Overall, we were able to accurately predict that θ values would have a significant effect on penetration
performance, and that α values would have no significant effect on performance. The trend that we
observed for θ was surprisingly reversed. With the sharper penetration tip of a high θ, a much higher
force was felt, meaning the penetration pressure was far higher than that of a low θ tip. This is likely due to
an unforeseen property of fibrous solids, wherein the fibrous fibrin network inside of the thrombus sample
exponentially increased the stiffness of the sample when displaced. When the high θ tipped geometries
indented the surface of the sample, it displaced the fibrous network and thus a much higher pressure was
needed to penetrate the sample.
A table summarizing our findings for this objective is shown below, in Table 1.
The second objective of minimal force during forward slicing involves the ANOVA for average forward
force. At both significance levels of 0.05 and 0.01, the critical F values for θ, α, and the combination were
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TABLE I – F Values from Analysis of Variance
(F Values) Penetration Forward Weight Backward F Critical (0.05) F Critical (0.01)
θ 46.647 15.525 2.509 2.935 3.403 5.614
α 0.535 2.596 4.223 0.555 3.009 4.718
Combination 1.338 1.583 1.368 2.072 2.508 3.667
unchanged. The F value for α was 2.596, which was close to the critical F value for 0.05 significance, but
we failed to reject our null hypothesis that α had little to no effect. When compared to the critical F value
for 0.01 significance, we do not reject our null hypothesis with more certainty. This is consistent with
our initial hypothesis that α would have little to no impact on the force required for forward movement.
The F value for θ was 15.525, meaning we were able to soundly reject the null hypothesis that θ had
no significant impact on performance, for both 0.05 and 0.01 significance. This matches our hypothesis
that θ would affect the performance of the geometry during forward movement, and the trend is also as
expected. The high θ value of 70 outperformed the lower θ values, following the expectations laid out in
the hypothesis. The critical F value for the interaction between θ and α was 1.583, meaning we are unable
to reject that the combination of θ and α had no significant difference in forward movement performance.
This was noted for both levels of significance that were tested.
The third objective of maximal chip/emboli removal during backwards motion involves the ANOVA
for average backwards force and the ANOVA for the change in weight in the sample. Again, at both
significance levels, the critical F values remained unchanged. The backwards force ANOVA resulted in
F values for all parameters that were below the critical F value for 0.05 significance level, meaning we
failed to reject our null hypothesis that either variable or the combination of both had little to no effect
on backwards force. Indicating that the variations in tested designs had no statistically significant effect
on backwards force, and future testing will have to introduce another variable that will have an effect on
backwards force.
The ANOVA for weight lost had the F value for α at 4.223, which was higher than the critical F value
for a significance of 0.05, but when held under higher scrutiny at a significance level of 0.01, it was
found to be lower than the critical F value. So, while we are tempted to reject our null hypothesis that
α had no effect on the amount of sample removed in a single trial, we are unable to do so with 99%
confidence. It is likely that α has some effect on the mass removed by a geometry, but it is also possible
that there are other factors that affect the mass removal, such as surface roughness of the sample or the
samples microstructure and composition. This result somewhat confirms the hypothesis that α will impact
the weight removal, but also raises questions as to what other variables will aid in the weight removal
aspect of a geometry. This will be further discussed in the future plans section. The F value for θ was
2.509, which is less than the critical F values for both significance levels, thus we fail to reject the null
hypothesis that θ had little to not effect on weight removal. This is in line with the initial hypothesis.
Our results indicated that the θ angle was very impactful to penetration performance as well as the
forward movement performance. However, the trend was the reverse of what was expected. This may
be due to the mechanical properties of a fibrous solid, wherein the fibrous network inside the solid
exponentially increases the stiffness of the material as it is deformed. This result prompted a second set
of experimentation, with a non-fibrous sample being tested instead of the fibrous thrombus sample. As
we knew the α angle had little to no effect on any performance objective, we only varied the θ angle and
kept the α angle constant at 0.
IV. CONCLUSION
In this experiment, we printed 13 agitator geometries that were varied in two angles, the α angle and
the θ angle. We then ran each geometry for three trials through a 20 mL thrombus sample inside of a 50
mL Falcon centrifuge tube, while recording the forces felt by the geometries and the changes in weight
of the samples. The data set was then analyzed by running a two way ANOVA to analyze the impact
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that both variables, α and θ, had. With the ANOVA tests, we were able to confirm the importance of a
shear cutting angle, or the θ angle, for penetration and forward movement of our agitator geometry. We
also established that variations in the α angle had little to no effect on the geometry’s performance for
penetration and forward movement. Finally, we found that the α angle had some effect on the removal of
the sample during backwards movement, but there are likely other factors in play that we were unable to
account for. Factors such as the roughness of the surface would affect the surface adhesion of the chips
from the sample to the geometry, aiding the geometry in the sample removal. With the resources and level
of 3D printing that was utilized in this experiment, it would be very difficult to consistently ensure the
same level of surface roughness for every geometry, and even harder to vary the level of surface roughness
to desired degrees.
A. Future Work
In the future, we would like to perform this experiment set again, but replacing the α variations with a
new angle variant. This angle would affect the curvature of the fins, such that they spiral helically around
the center. We believe this will impact the backwards force felt by the geometry as well as the fraction of
the sample that is removed more so than the α angle. In this study, we were limited by the 3D printing
capabilities causing us to be unable to reliably print samples with varying radial spirals. In the future, a
higher quality 3D printer will be utilized to reliably print more intricate geometries. In addition, a higher
quality printer may allow for surface roughness to be varied with consistency, allowing experiments into
not only geometries but also surface conditions.
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Fig. 22 – Rheology data of frequency sweep from 0.1-10 rad/s.
Fig. 23 – Rheology data of frequency sweep from 0.1-1 rad/s.
Fig. 24 – Rheology data of strain sweep from 0-0.1. Frequency held at 0.5.








Fig. 27 – Smoothing matlab code used on clot sample data.
Fig. 28 – Smoothing matlab code used on agar sample data.
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APPENDIX D
RAW DATA AND ANOVA ANALYSIS FOR CLOT SAMPLES
Fig. 29 – Complete data collected for clot samples.
Fig. 30 – Complete data collected for agar samples.
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Fig. 31 – ANOVA analysis used on peak penetration forces. Varied by α and θ.
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Fig. 32 – ANOVA analysis used on forward movement forces. Varied by α and θ.
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Fig. 33 – ANOVA analysis used on change in weight in sample. Varied by α and θ.
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Fig. 34 – ANOVA analysis used on backward movement forces. Varied by α and θ.
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APPENDIX E
COMPLETE RAW DATA GRAPHS
Fig. 35 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Top is (0,0), bottom is (0,20).
Fig. 36 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Top is (0,45), bottom is (0,70).
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Fig. 37 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Top is (15,20), bottom is (15,45).
Fig. 38 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Top is (15,70), bottom is (30,20).
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Fig. 39 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Top is (30,45), bottom is (30,70).
Fig. 40 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Top is (45,20), bottom is (45,45).
Fig. 41 – Force to time data graphs for clot sample. Taken from VI. 3 trials per row. Row is (45,70).
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Fig. 42 – Force to time data graphs for agar sample. Taken from VI. 3 trials per row. Top is (0,0), bottom is (0,20).
Fig. 43 – Force to time data graphs for agar sample. Taken from VI. 3 trials per row. Top is (0,45), bottom is (0,70).
